1984
DOI: 10.1007/bf00540261
|View full text |Cite
|
Sign up to set email alerts
|

Fatty acid pattern of platelet phospholipids in cystic fibrosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
6
0

Year Published

1989
1989
2022
2022

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 8 publications
(6 citation statements)
references
References 6 publications
0
6
0
Order By: Relevance
“…Docosahexaenoic acid deficiency in CF subjects has been previously reported by studying the fatty acid composition of serum [4] and red blood cell PLs [40], but, as far as we know, the localization of this deficiency in particular molecular species is reported in this paper for the first time. This result might be important because pPE species are known to have an antioxidative action involved in scavenging radicals at the vinyl ether linkage, and to protect membrane against peroxidation [41][42][43].…”
Section: Discussionmentioning
confidence: 68%
See 1 more Smart Citation
“…Docosahexaenoic acid deficiency in CF subjects has been previously reported by studying the fatty acid composition of serum [4] and red blood cell PLs [40], but, as far as we know, the localization of this deficiency in particular molecular species is reported in this paper for the first time. This result might be important because pPE species are known to have an antioxidative action involved in scavenging radicals at the vinyl ether linkage, and to protect membrane against peroxidation [41][42][43].…”
Section: Discussionmentioning
confidence: 68%
“…On the contrary, statistical differences found between normal and CF patients with P ins , in the PC species corresponding to m/z 820.4 and m/z 792,4, account for 3,8%, and the sum of targeted species constitute 12% of this class in normal subjects. Therefore, these data might be considered reliable and fit with the ones from literature obtained in other blood cells by means of GC analysis of fatty acids [40].…”
Section: Discussionmentioning
confidence: 86%
“…Interestingly, parallel to this decrease in PUFA, increases in the levels of SFA, and more specifically Palmitate (16:0) and Stearate (18:0) have also been reported in CF individuals, particularly in circulating lipids, namely NEFA and Cholesteryl esters [36,37] and in PL extracted from lung samples, i. e. bronchial secretions [20] and freshly dissociated bronchial epithelial cells [17,18]. Altogether, these cumulative processes result in an overall FA imbalance towards more saturated species.…”
Section: Constant Dysregulation Of Fatty Acid Profile In Cfmentioning
confidence: 82%
“…The old report about LA deficiency in CF has been confirmed in different blood compartments [51][52][53] and in various tissues [54][55][56][57]. Many studies of supplementation with LA have been performed, but were often of relatively short duration and, lacking in stable study conditions, not resulting in clear outcomes and motivating general recommendations.…”
Section: Fatty Acid Abnormalities In Cfmentioning
confidence: 99%